An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin.
Saved in:
| Title: | An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin. |
|---|---|
| Authors: | Sneed SL; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and., Reese BB; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and., Laureano AF; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and., Ratnapriya S; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and., Fraschilla I; Center for the Study of Inflammatory Bowel Disease, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Jeffrey KL; Center for the Study of Inflammatory Bowel Disease, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Coffey GP; Nuvig Therapeutics, Redwood City, California, USA., Conley PB; Nuvig Therapeutics, Redwood City, California, USA., Anthony RM; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2024 Feb 15; Vol. 134 (4). Date of Electronic Publication: 2024 Feb 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38357917 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sneed+SL%22">Sneed SL</searchLink>; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and.<br /><searchLink fieldCode="AU" term="%22Reese+BB%22">Reese BB</searchLink>; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and.<br /><searchLink fieldCode="AU" term="%22Laureano+AF%22">Laureano AF</searchLink>; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and.<br /><searchLink fieldCode="AU" term="%22Ratnapriya+S%22">Ratnapriya S</searchLink>; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and.<br /><searchLink fieldCode="AU" term="%22Fraschilla+I%22">Fraschilla I</searchLink>; Center for the Study of Inflammatory Bowel Disease, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Jeffrey+KL%22">Jeffrey KL</searchLink>; Center for the Study of Inflammatory Bowel Disease, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Coffey+GP%22">Coffey GP</searchLink>; Nuvig Therapeutics, Redwood City, California, USA.<br /><searchLink fieldCode="AU" term="%22Conley+PB%22">Conley PB</searchLink>; Nuvig Therapeutics, Redwood City, California, USA.<br /><searchLink fieldCode="AU" term="%22Anthony+RM%22">Anthony RM</searchLink>; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, and. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2024 Feb 15; Vol. 134 (4). <i>Date of Electronic Publication: </i>2024 Feb 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38357917 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI172980 Languages: – Code: eng Text: English Titles: – TitleFull: An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sneed SL – PersonEntity: Name: NameFull: Reese BB – PersonEntity: Name: NameFull: Laureano AF – PersonEntity: Name: NameFull: Ratnapriya S – PersonEntity: Name: NameFull: Fraschilla I – PersonEntity: Name: NameFull: Jeffrey KL – PersonEntity: Name: NameFull: Coffey GP – PersonEntity: Name: NameFull: Conley PB – PersonEntity: Name: NameFull: Anthony RM IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 02 Text: 2024 Feb 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 134 – Type: issue Value: 4 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |
